A detailed history of Fred Alger Management, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 134,262 shares of GH stock, worth $3.88 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
134,262
Previous 51,316 161.64%
Holding current value
$3.88 Million
Previous $1.39 Million 99.5%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $1.42 Million - $2.23 Million
82,946 Added 161.64%
134,262 $2.77 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $10,962 - $14,986
-508 Reduced 0.98%
51,316 $1.39 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $1.34 Million - $2.07 Million
51,824 New
51,824 $1.54 Million
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $10,955 - $16,137
-478 Reduced 4.56%
10,000 $234,000
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $2.63 Million - $6.17 Million
-103,268 Reduced 90.79%
10,478 $285,000
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $133,206 - $186,111
-3,051 Reduced 2.61%
113,746 $6.12 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $7.29 Million - $19.6 Million
-252,878 Reduced 68.41%
116,797 $4.71 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $66.6 Million - $139 Million
-1,380,516 Reduced 78.88%
369,675 $24.5 Million
Q4 2021

Feb 14, 2022

SELL
$88.71 - $120.43 $81 Million - $110 Million
-913,431 Reduced 34.29%
1,750,191 $175 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $13.9 Million - $18.7 Million
-141,172 Reduced 5.03%
2,663,622 $333 Million
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $18.4 Million - $27.7 Million
167,305 Added 6.34%
2,804,794 $348 Million
Q1 2021

May 17, 2021

BUY
$127.04 - $179.1 $72 Million - $102 Million
567,042 Added 27.39%
2,637,489 $403 Million
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $12.7 Million - $17.2 Million
126,880 Added 6.53%
2,070,447 $267 Million
Q3 2020

Nov 13, 2020

SELL
$80.32 - $111.8 $11.9 Million - $16.5 Million
-147,548 Reduced 7.06%
1,943,567 $217 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $54 Million - $87 Million
892,602 Added 74.48%
2,091,115 $170 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $8.04 Million - $12.1 Million
-136,247 Reduced 10.21%
1,198,513 $83.4 Million
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $64.1 Million - $89.2 Million
1,077,513 Added 418.86%
1,334,760 $104 Million
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $2.57 Million - $4.53 Million
-41,062 Reduced 13.76%
257,247 $16.4 Million
Q2 2019

Aug 14, 2019

BUY
$63.94 - $91.11 $12.5 Million - $17.8 Million
195,148 Added 189.17%
298,309 $25.8 Million
Q1 2019

May 14, 2019

BUY
$34.3 - $97.98 $1.17 Million - $3.33 Million
34,032 Added 49.23%
103,161 $7.91 Million
Q4 2018

Feb 14, 2019

BUY
$29.2 - $46.1 $2.02 Million - $3.19 Million
69,129 New
69,129 $2.6 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.95B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.